Wojciech G Polak, Andrzej Gladysz, Katarzyna Rotter
Ann Transplant 2005; 10(3): 11-16
Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus
(HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.
Keywords: Liver Transplantation, Hepatitis B, Recurrence, prevention, Hepatitis B Immunoglobuline, Lamivudine, Adefovir, Vaccination